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Background: Whether microalbuminuria (MICRO) in non-diabetic patients with metabolic syndrome (METS) influences subclinical atherosclerosis 
(SCA), quantified by coronary artery calcification (CAC) is unknown.
Methods: The study comprised 6814 asymptomatic men and women (52.85%), aged 45-84 yrs without prior cardiovascular disease, enrolled in 
the Multi-Ethnic Study of Atherosclerosis. Baseline measures assessed in all patients included urine albumin-creatinine ratio and coronary artery 
calcium (Agatston score) quantified by chest CT scanning. The 5907 non-diabetic individuals were divided based on the presence/absence of METS 
(National Cholesterol Education Program definition) and MICRO (30-300 mg/g) into 4 groups: 1) No METS + No MICRO (reference group) [70%] 2) 
MICRO-only [4%] 3) METS-only [23.3%] 4) METS+MICRO [2.7%]. Association with any CAC (CAC >0) and CAC 75th percentile was examined using 
multivariate logistic regression.
Results: Prevalence of CAC>0 was highest in METS+MICRO group (68.52%) compared to METS-only (54.18%) and reference group (44.54%). 
METS+MICRO was more predictive of coronary artery calcification as compared to METS alone in all races except Chinese on regression analysis 
(Table 1). This association was strongest in whites.
Conclusions: Microalbuminuria in non-diabetic patients with metabolic syndrome is an incremental predictor of SCA in the large majority of ethnic 
subgroups, and might explain recent findings of worse cardiovascular outcomes in this setting. 
Crude and adjusted Odds Ratio (OR β) estimates associated with metabolic syndrome and microalbuminuria
Agatston score α CAC> 0 CAC > 75th pct
Group (n) Mean (Min-Max) OR 95% CI OR 95% CI
A. Unadjusted OR 
MICRO only (235) 224.47 (0-6062.64) 1.74 1.333-2.272* 1.726 1.303-2.286*
METS only (1377) 142.39 (0-4602.14) 1.472 1.302-1.664* 1.387 1.208-1.592*
MICRO+METS (162) 247.48 (0-3253.58) 2.709 1.934-3.795* 3.069 2.235-4.214*
B. Adjusted for age, gender and ethnicity
MICRO only -- 1.259 0.909-1.743 1.123 0.797-1.583
METS only -- 1.622 1.402-1.876* 1.559 1.322-1.837*
MICRO+METS -- 2.107 1.390-3.195* 2.676 1.794-3.991*
C. Adjusted for above variables and known confounders†
MICRO only -- 1.194 0.847 -1.683 1.105 0.762-1.601
METS only -- 1.423 1.215-1.667* 1.359 1.135-1.627*
MICRO+METS -- 2.015 1.303-3.118* 2.541 1.667-3.875*
D. Race stratified analysis adjusted for age, gender and known confounders†
Whites METS only (589) 214.1 (0-4602.14) 1.635 1.302-2.052* 1.763 1.391-2.234*
MICRO+METS (56) 394.77 (0-3253.58) 3.186 1.331-7.624* 3.915 1.866-8.216*
Chinese METS only (108) 84.56 (0-1193.51) 2.365 0.502-3.905 1.063 0.585 -1.929
MICRO+METS (24) 163.86 (0-1306.13) 1.4 0.502-3.905 1.042 0.346-3.134
Blacks METS only (327) 83.66 (0-3172.2) 1.322 0.985-1.775 1.396 0.973-2.002
MICRO+METS (39) 232.95 (0-1927.43) 1.841 0.847-4.004 3.26 1.478-7.187*
Hispanics METS only (353) 94.85 (0-2228.59) 1.582 1.169-2.141* 1.323 0.919-1.905
MICRO+METS (43) 115.51 (0-674.09) 1.996 0.929-4.289 2.216 1.034-4.746*
†Adjusted in addition for smoking, family history of cardiovascular disease, LDL, antihypertensive medications, statin therapy, and serum creatinine.  Phantom adjusted mean Agatston score calculated using 
electron-beam computed tomography and multidetector row helical computed tomography
β In comparison to reference group (No METS + No MICRO). 
* Statistically significant
